EBS
Emergent BioSolutions Inc.Healthcare$8.23
▲ Bullish
Mkt Cap: $426.1M|Float: 46.8M|SI: 19.0%|DTC: 7.7
Data as of market close Apr 2, 2026
IV Rank
59
IV Pctl
44%
HV 20d
27.9%
52W Range
$4-$14
ATR(14)
$0.30
Exp. Move
±12.4%
P/C Ratio
0.20
Earnings
May 6
GEX Positive
DEX Long
Net Put Premium
IV Moderate
Max Pain Above
Exp. Move Wide
Low Put/Call
EBS Key Options Data
- IV Rank
- 59.1%
- Total GEX
- $0.00B
- Total DEX
- $0.4M
- Max Pain
- $9.00
- Expected Move
- ±12.4%
- Put/Call OI
- 0.20
- Net Premium
- $-0.1M
- Spot Price
- $8.23
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.02 | ±12.4% | $7.20 | $9.25 |
| 2026-05-15 | 43 | ±$1.12 | ±13.7% | $7.10 | $9.35 |
| 2026-06-18 | 77 | ±$2.25 | ±27.3% | $5.98 | $10.48 |
| 2026-09-18 | 169 | ±$1.92 | ±23.4% | $6.30 | $10.15 |
| 2027-01-15 | 288 | ±$4.05 | ±49.2% | $4.18 | $12.28 |
Explore EBS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.